Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys

Experimental and Clinical Psychopharmacology

Volumn 12, Issue 3, 2004, Pages 163-172

  Beardsley, Patrick M ^a   Aceto, Mario D ^a   Cook, Charles D ^a   Bowman, Edward R ^a   Newman, Jennifer L ^a   Harris, Louis S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BENZOQUINONE; DIAMORPHINE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; OXYCODONE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG MECHANISM; DRUG SELF ADMINISTRATION; HOT PLATE TEST; MALE; MEDICAL DOCUMENTATION; MORPHINE ADDICTION; MOUSE; NONHUMAN; RAT; REINFORCEMENT; RHESUS MONKEY; SUBSTANCE ABUSE; TAIL FLICK TEST; WITHDRAWAL SYNDROME; WRITHING TEST;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; INHIBITORY CONCENTRATION 50; MACACA MULATTA; MALE; MICE; MICE, INBRED ICR; MORPHINE; NARCOTICS; NOCICEPTORS; OXYCODONE; PAIN MEASUREMENT; RATS; RATS, LONG-EVANS; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 3342924054     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.12.3.163     Document Type: Article

References (46)

1. Aceto, M. D., Bowman, E. R., Harris, L. S., Hughes, L. D., Kipps, B. R., & May, E. L. (2003). Dependence studies of new compounds in the rhesus monkey, rat and mouse (2002). In W. L. Dewey & L. S. Harris (Eds.), Problems of Drug Dependence, 2002: Proceedings of the 64th Annual Scientific Meeting, The Committee on Problems of Drug Dependence (NIDA Research Monograph 183, pp. 191-227). Bethesda, MD: U.S. Department of Health and Human Services.
2. Aceto, M. D., Bowman, E. R., Harris, L. S., & May, E. L. (1992). Dependence studies of new compounds in the rhesus monkey and mouse (1991). In L. S. Harris (Ed.), Problems of Drug Dependence, 1991: Proceedings of the 53rd Annual Scientific Meeting, The Committee on Problems of Drug Dependence (NIDA Research Monograph 119, pp. 513-558). Rockville, MD: U.S. Department of Health and Human Services.
3. Aceto, M. D., Bowman, E. R., Harris, L. S., & May, E. L. (1996). Dependence studies of new compounds in the rhesus monkey, rat and mouse (1995). In L. S. Harris (Ed.), Problems of Drug Dependence, 1995: Proceedings of the 57th Annual Scientific Meeting, The Committee on Problems of Drug Dependence (NIDA Research Monograph 162, pp. 408-451). Rockville, MD: U.S. Department of Health and Human Services.
4. Aceto, M. D., Bowman, E. R., Harris, L. S., & May, E. L. (1997). Dependence studies of new compounds in the rhesus monkey, rat and mouse (1996). In L. S. Harris (Ed.), Problems of Drug Dependence, 1996: Proceedings of the 58th Annual Scientific Meeting, The Committee on Problems of Drug Dependence (NIDA Research Monograph 174, pp. 338-395). Rockville, MD: U.S. Department of Health and Human Services.
5. Aceto, M. D., Flora, R. E., & Harris, L. S. (1977). The effects of naloxone and nalorphine during the development of morphine dependence in rhesus monkeys. Pharmacologist, 15, 1-9.
6. Aceto, M. D., Harris, L. S., & Bowman, E. R. (1997). Etorphines: Mu-opioid receptor-selective antinociception and low physical dependence capacity. European Journal of Pharmacology, 338, 215-223.
7. Atwell, L., & Jacobson, A. E. (1978). A search for less harmful analgesics. Lab Animal, 7, 42-47.
8. Beardsley, P. M., & Harris, L. S. (1997). Evaluation of the discriminative stimulus and reinforcing effects of dihydroetorphine. Drug and Alcohol Dependence, 48, 77-84.
9. Bowen, C. A., Fischer, B. D., Mello, N. K., & Negus, S. S. (2002). Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 302, 264-273.
10. Broqua, P., Wettstein, J. G., Rocher, M. N., Riviere, P. J., & Dahl, S. G. (1998). The discriminative stimulus properties of U50,488 and morphine are not shared by fedotozine. European Neuropsychopharmacology, 8, 261-266.
11. Carey, G. J., & Bergman, J. (2001). Enadoline discrimination in squirrel monkeys: Effects of opioid agonists and antagonists. Journal of Pharmacology and Experimental Therapeutics, 297, 215-223.
12. Carter, R. B. (1991). Differentiating analgesic and non-analgesic drug activities on rat hot plate: Effect of behavioral endpoint. Pain, 47, 211-220.
13. Cleary, J., Mikus, G., Somogyi, A., & Bochner, F. (1994). The influence of pharmacogenetics on opioid analgesia: Studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model. Journal of Pharmacology and Experimental Therapeutics, 271, 1528-1534.
14. 2 dopamine antagonists decrease response rates of food-maintained behavior and reduce the discriminative stimulus produced by heroin. Pharmacology Biochemistry and Behavior, 35, 351-355.
15. Crane, E. (2003). The DAWN Report. Washington, DC: Substance Abuse and Mental Health Services Administration.
16. D'Amour, F. E., & Smith, D. L. (1941). A method for determining loss of pain sensation. Journal of Pharmacology and Experimental Therapeutics, 72, 74-79.
17. Deneau, G. A. (1956). An analysis of the factors influencing the development of physical dependence to narcotic analgesics in the rhesus monkey with methods for predicting physical dependence liability in man. Unpublished doctoral dissertation, University of Michigan.
18. Dewey, W. L., Harris, L. S., Howes, J. F., & Nuite, J. A. (1970). The effects of various neurohormonal regulators on the activity of morphine and narcotic antagonists in the tail-flick and phenylquinone tests. Journal of Pharmacology and Experimental Therapeutics, 175, 435-442.
19. Duttaroy, A., & Yoburn, B. C. (1995). The effect of intrinsic efficacy on opioid tolerance. Anesthesiology, 82, 1226-1236.
20. Dykstra, L. A., Preston, K. L., & Bigelow, G. E. (1997). Discriminative stimulus and subjective effects of opioids with mu and kappa activity: Data from laboratory animals and human subjects. Psychopharmacology (Berl), 130, 14-27.
21. Eddy, N. B., Halbach, H., & Braenden, O. J. (1956). Synthetic substances with morphine-like effect. Bulletin of the World Health Organization, 14, 353-402.
22. Eddy, N. B., & Leimbach, D. (1953). Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. Journal of Pharmacology and Experimental Therapeutics, 107, 385-393.
23. Fukagawa, Y., Katz, J. L., & Suzuki, T. (1989). Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats. European Journal of Pharmacology, 170, 47-51.
24. Gmerek, D. E., & Woods, J. H. (1986). Kappa receptor mediated opioid dependence in rhesus monkeys. Life Sciences, 39, 987-992.
25. Holtzman, S. G., Cook, L., & Steinfels, G. F. (1991). Discriminative stimulus effects of spiradoline, a kappa-opioid agonist. Psychopharmacology (Berl), 105, 447-452.
26. Joranson, D. E., Ryan, K. M., Gilson, A. M., & Dahl, J. L. (2000). Trends in medical use and abuse of opioid analgesics. Journal of the American Medical Association, 283, 1710-1714.
27. Koob, G. F., Vaccarino, F. J., Amalric, M., & Bloom, F. E. (1986). Neurochemical substrates for opiate reinforcement. In R. M. Brown, D. H. Clouet, & D. P. Friedman (Eds.), Opiate receptor subtypes and brain function (NIDA Research Monograph 71, pp. 146-164). Rockville, MD: U.S. Department of Health and Human Services.
28. Litchfield, J. T., & Wilcoxon, F. A. (1949). A simplified method of evaluating dose effect experiments. Journal of Pharmacology and Experimental Therapeutics, 96, 99-113.
29. Ma, H. C., Dohi, S., Wang, Y. F., Ishizawa, Y., & Yanagida, F. (2001). The antinociceptive and sedative effects of carbachol and oxycodone administered into brainstem pontine reticular formation and spinal subarachnoid space in rats. Anesthesia and Analgesia, 92, 1307-1315.
30. Martin, T. J., DeMontis, M. G., Kim, S. A., Sizemore, G. M., Dworkin, S. I., & Smith, J. E. (1998). Effects of beta-funaltrexamine on dose-effect curves for heroin self-administration in rats: Comparison with alteration of [3H]DAMGO binding to rat brain sections. Drug and Alcohol Dependence, 52, 135-147.
31. Mello, N. K., Negus, S. S., Lukas, S. E., Mendelson, J. H., Sholar, J. W., & Drieze, J. (1995). A primate model of polydrug abuse: Cocaine and heroin combinations. Journal of Pharmacology and Experimental Therapeutics, 274, 1325-1337.
32. National Research Council, Institute of Laboratory Animal Resources, Commission on Life Sciences. (1996). Guide to the care and use of laboratory animals. Washington, DC: National Academy Press.
33. Negus, S. S., Picker, M. J., & Dykstra, L. A. (1990). Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure. Psychopharmacology (Berl), 102, 465-473.
34. Nielsen, C. K., Ross, F. B., & Smith, M. T. (2000). Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat. Journal of Pharmacology and Experimental Therapeutics, 295, 91-99.
35. Pedigo, N. W., Dewey, W. L., & Harris, L. S. (1975). Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. Journal of Pharmacology and Experimental Therapeutics, 193, 845-852.
36. Picker, M., & Dykstra, L. A. (1987). Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons. Journal of Pharmacology and Experimental Therapeutics, 243, 938-945.
37. Platt, D. M., Rowlett, J. K., & Spealman, R. D. (2001). Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: Opioid and dopaminergic mechanisms. Journal of Pharmacology and Experimental Therapeutics, 299, 760-767.
38. Poyhia, R., & Kalso, E. A. (1992). Antinociceptive effects and central nervous system depression caused by oxycodone and morphine in rats. Pharmacology and Toxicology, 70, 125-130.
39. Raynor, K., Kong, H., Chen, Y., Yasuda, K., Yu, L., Bell, G. I., & Reisine, T. (1994). Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Molecular Pharmacology, 45, 330-334.
40. Roberts, A. J., Polis, I. Y., & Gold, L. H. (1997). Intravenous self-administration of heroin, cocaine, and the combination in Balb/c mice. European Journal of Pharmacology, 326, 119-125.
41. Ross, F. B., & Smith, M. T. (1997). The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain, 73, 151-157.
42. Ross, F. B., Wallis, S. C., & Smith, M. T. (2000). Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats. Pain, 84, 421-428.
43. Self, D. W., & Stein, L. (1992). Receptor subtypes in opioid and stimulant reward. Pharmacology and Toxicology, 70, 87-94.
44. Woods, J. H., Ko, M.-C., Winger, G., France, C. P., & Traynor, J. R. (2003). Evaluation of new compounds for opioid activity 2002. In W. L. Dewey & L. S. Harris (Eds.), Problems of Drug Dependence, 2002: Proceedings of the 64th Annual Scientific Meeting, The College on Problems of Drug Dependence (NIDA Research Monograph 183, pp. 170-189). Bethesda, MD: U.S. Department of Health and Human Services.
45. Wurster, R. M., Griffiths, R. R., Findley, J. D., & Brady, J. V. (1977). Reduction of heroin self-administration in baboons by manipulation of behavioral and pharmacological conditions. Pharmacology Biochemistry and Behavior, 7, 519-528.
46. Yoburn, B. C., Shah, S., Chan, K., Duttaroy, A., & Davis, T. (1995). Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivity. Pharmacology Biochemistry and Behavior, 51, 535-539.